The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
What we do
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.